+1 (704) 266-3234

Global Drug Of Abuse (DOA) Testing Market Insights, Forecast To 2025

Published on: Dec 2018 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 115

Drugs of abuse testingis the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat.
During the forecast period, the Drug of Abuse (DOA) Testing market is expected to witness the fastest growth in the APAC region.
The global Drug of Abuse (DOA) Testing market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Drug of Abuse (DOA) Testing market based on company, product type, end user and key regions.

This report studies the global market size of Drug of Abuse (DOA) Testing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug of Abuse (DOA) Testing in these regions.
This research report categorizes the global Drug of Abuse (DOA) Testing market by top players/brands, region, type and end user. This report also studies the global Drug of Abuse (DOA) Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Express Diagnostics Int'l
Psychemedics

Market size by Product
Urine
Saliva
Hair
Others
Market size by End User
Hospitals
Laboratories
Workplace
At-Home

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drug of Abuse (DOA) Testing market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Drug of Abuse (DOA) Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug of Abuse (DOA) Testing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug of Abuse (DOA) Testing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drug of Abuse (DOA) Testing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug of Abuse (DOA) Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Drug of Abuse (DOA) Testing Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Product
1.4.2 Urine
1.4.3 Saliva
1.4.4 Hair
1.4.5 Others
1.5 Market by End User
1.5.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Laboratories
1.5.4 Workplace
1.5.5 At-Home
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drug of Abuse (DOA) Testing Market Size
2.1.1 Global Drug of Abuse (DOA) Testing Revenue 2013-2025
2.1.2 Global Drug of Abuse (DOA) Testing Sales 2013-2025
2.2 Drug of Abuse (DOA) Testing Growth Rate by Regions
2.2.1 Global Drug of Abuse (DOA) Testing Sales by Regions
2.2.2 Global Drug of Abuse (DOA) Testing Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Drug of Abuse (DOA) Testing Sales by Manufacturers
3.1.1 Drug of Abuse (DOA) Testing Sales by Manufacturers
3.1.2 Drug of Abuse (DOA) Testing Sales Market Share by Manufacturers
3.1.3 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.2 Drug of Abuse (DOA) Testing Revenue by Manufacturers
3.2.1 Drug of Abuse (DOA) Testing Revenue by Manufacturers (2013-2018)
3.2.2 Drug of Abuse (DOA) Testing Revenue Share by Manufacturers (2013-2018)
3.3 Drug of Abuse (DOA) Testing Price by Manufacturers
3.4 Drug of Abuse (DOA) Testing Manufacturing Base Distribution, Product Types
3.4.1 Drug of Abuse (DOA) Testing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug of Abuse (DOA) Testing Product Type
3.4.3 Date of International Manufacturers Enter into Drug of Abuse (DOA) Testing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Drug of Abuse (DOA) Testing Sales by Product
4.2 Global Drug of Abuse (DOA) Testing Revenue by Product
4.3 Drug of Abuse (DOA) Testing Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Drug of Abuse (DOA) Testing Breakdown Data by End User

6 North America
6.1 North America Drug of Abuse (DOA) Testing by Countries
6.1.1 North America Drug of Abuse (DOA) Testing Sales by Countries
6.1.2 North America Drug of Abuse (DOA) Testing Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drug of Abuse (DOA) Testing by Product
6.3 North America Drug of Abuse (DOA) Testing by End User

7 Europe
7.1 Europe Drug of Abuse (DOA) Testing by Countries
7.1.1 Europe Drug of Abuse (DOA) Testing Sales by Countries
7.1.2 Europe Drug of Abuse (DOA) Testing Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug of Abuse (DOA) Testing by Product
7.3 Europe Drug of Abuse (DOA) Testing by End User

8 Asia Pacific
8.1 Asia Pacific Drug of Abuse (DOA) Testing by Countries
8.1.1 Asia Pacific Drug of Abuse (DOA) Testing Sales by Countries
8.1.2 Asia Pacific Drug of Abuse (DOA) Testing Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drug of Abuse (DOA) Testing by Product
8.3 Asia Pacific Drug of Abuse (DOA) Testing by End User

9 Central & South America
9.1 Central & South America Drug of Abuse (DOA) Testing by Countries
9.1.1 Central & South America Drug of Abuse (DOA) Testing Sales by Countries
9.1.2 Central & South America Drug of Abuse (DOA) Testing Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drug of Abuse (DOA) Testing by Product
9.3 Central & South America Drug of Abuse (DOA) Testing by End User

10 Middle East and Africa
10.1 Middle East and Africa Drug of Abuse (DOA) Testing by Countries
10.1.1 Middle East and Africa Drug of Abuse (DOA) Testing Sales by Countries
10.1.2 Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drug of Abuse (DOA) Testing by Product
10.3 Middle East and Africa Drug of Abuse (DOA) Testing by End User

11 Company Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Company Business Overview
11.1.3 Siemens Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Siemens Drug of Abuse (DOA) Testing Products Offered
11.1.5 Siemens Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Merck Drug of Abuse (DOA) Testing Products Offered
11.2.5 Merck Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.Roche Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Roche Drug of Abuse (DOA) Testing Products Offered
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Company Business Overview
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products Offered
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Company Business Overview
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Bio-Rad Drug of Abuse (DOA) Testing Products Offered
11.5.5 Bio-Rad Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Company Business Overview
11.6.3 Abbott Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Abbott Drug of Abuse (DOA) Testing Products Offered
11.6.5 Abbott Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Company Business Overview
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Products Offered
11.7.5 Quest Diagnostics Recent Development
11.8 Express Diagnostics Int'l
11.8.1 Express Diagnostics Int'l Company Details
11.8.2 Company Business Overview
11.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Products Offered
11.8.5 Express Diagnostics Int'l Recent Development
11.9 Psychemedics
11.9.1 Psychemedics Company Details
11.9.2 Company Business Overview
11.9.3 Psychemedics Drug of Abuse (DOA) Testing Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Psychemedics Drug of Abuse (DOA) Testing Products Offered
11.9.5 Psychemedics Recent Development

12 Future Forecast
12.1 Drug of Abuse (DOA) Testing Market Forecast by Regions
12.1.1 Global Drug of Abuse (DOA) Testing Sales Forecast by Regions 2018-2025
12.1.2 Global Drug of Abuse (DOA) Testing Revenue Forecast by Regions 2018-2025
12.2 Drug of Abuse (DOA) Testing Market Forecast by Product
12.2.1 Global Drug of Abuse (DOA) Testing Sales Forecast by Product 2018-2025
12.2.2 Global Drug of Abuse (DOA) Testing Revenue Forecast by Product 2018-2025
12.3 Drug of Abuse (DOA) Testing Market Forecast by End User
12.4 North America Drug of Abuse (DOA) Testing Forecast
12.5 Europe Drug of Abuse (DOA) Testing Forecast
12.6 Asia Pacific Drug of Abuse (DOA) Testing Forecast
12.7 Central & South America Drug of Abuse (DOA) Testing Forecast
12.8 Middle East and Africa Drug of Abuse (DOA) Testing Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug of Abuse (DOA) Testing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Drug of Abuse (DOA) Testing Product Picture
Table Drug of Abuse (DOA) Testing Market Segments
Table Key Manufacturers Drug of Abuse (DOA) Testing Covered
Table Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Drug of Abuse (DOA) Testing Sales Market Share by Product 2013-2025
Figure Urine Product Picture
Table Major Manufacturers of Urine
Figure Saliva Product Picture
Table Major Manufacturers of Saliva
Figure Hair Product Picture
Table Major Manufacturers of Hair
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Drug of Abuse (DOA) Testing Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospitals
Figure Laboratories
Figure Workplace
Figure At-Home
Figure Drug of Abuse (DOA) Testing Report Years Considered
Figure Global Drug of Abuse (DOA) Testing Market Size 2013-2025 (Million US$)
Figure Global Drug of Abuse (DOA) Testing Sales 2013-2025 (K Units)
Table Global Drug of Abuse (DOA) Testing Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Drug of Abuse (DOA) Testing Sales by Regions 2013-2018 (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Market Share by Regions 2013-2018
Figure Global Drug of Abuse (DOA) Testing Sales Market Share by Regions 2013-2018
Figure 2017 Global Drug of Abuse (DOA) Testing Sales Market Share by Regions
Table Global Drug of Abuse (DOA) Testing Revenue by Regions 2013-2018 (Million US$)
Table Global Drug of Abuse (DOA) Testing Revenue Market Share by Regions 2013-2018
Figure Global Drug of Abuse (DOA) Testing Revenue Market Share by Regions 2013-2018
Figure 2017 Global Drug of Abuse (DOA) Testing Revenue Market Share by Regions
Table Global Drug of Abuse (DOA) Testing Sales by Manufacturers (2013-2018) (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Share by Manufacturers (2013-2018)
Figure Global Drug of Abuse (DOA) Testing Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drug of Abuse (DOA) Testing Revenue by Manufacturers (2013-2018) (Million USD)
Table Drug of Abuse (DOA) Testing Revenue Share by Manufacturers (2013-2018)
Figure Drug of Abuse (DOA) Testing Value Share by Manufacturers in 2017
Table Key Manufacturers Drug of Abuse (DOA) Testing Price (2013-2018) (USD/Unit)
Table Drug of Abuse (DOA) Testing Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drug of Abuse (DOA) Testing Product Type
Table Date of International Manufacturers Enter into Drug of Abuse (DOA) Testing Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Share by Product (2013-2018)
Figure Global Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure Global Drug of Abuse (DOA) Testing Sales Market Share by Product in 2017
Table Global Drug of Abuse (DOA) Testing Revenue by Product (2013-2018) (Million US$)
Table Global Drug of Abuse (DOA) Testing Revenue Share by Product (2013-2018)
Figure Global Drug of Abuse (DOA) Testing Revenue Market Share by Product (2013-2018)
Figure Global Drug of Abuse (DOA) Testing Revenue Market Share by Product in 2017
Table Drug of Abuse (DOA) Testing Price by Product 2013-2018 (USD/Unit)
Table Global Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Share by End User (2013-2018)
Figure Global Sales Drug of Abuse (DOA) Testing Market Share by End User (2013-2018)
Figure Global Sales Drug of Abuse (DOA) Testing Market Share by End User in 2017
Figure North America Drug of Abuse (DOA) Testing Sales Growth Rate 2013-2018 (K Units)
Figure North America Drug of Abuse (DOA) Testing Revenue Growth Rate 2013-2018 (Million US$)
Table North America Drug of Abuse (DOA) Testing Sales by Countries (2013-2018) (K Units)
Table North America Drug of Abuse (DOA) Testing Sales Market Share by Countries (2013-2018)
Figure 2017 North America Drug of Abuse (DOA) Testing Sales Market Share by Countries
Table North America Drug of Abuse (DOA) Testing Revenue by Countries (2013-2018) (Million US$)
Table North America Drug of Abuse (DOA) Testing Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Drug of Abuse (DOA) Testing Revenue Market Share by Countries
Figure United States Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure United States Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Canada Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Table North America Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table North America Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure 2017 North America Drug of Abuse (DOA) Testing Market Share by Product
Table North America Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table North America Drug of Abuse (DOA) Testing Sales Market Share by End User (2013-2018)
Figure 2017 North America Drug of Abuse (DOA) Testing Market Share by End User
Figure Europe Drug of Abuse (DOA) Testing Sales Growth Rate 2013-2018 (K Units)
Figure Europe Drug of Abuse (DOA) Testing Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Drug of Abuse (DOA) Testing Sales by Countries (2013-2018) (K Units)
Table Europe Drug of Abuse (DOA) Testing Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Drug of Abuse (DOA) Testing Sales Market Share by Countries
Table Europe Drug of Abuse (DOA) Testing Revenue by Countries (2013-2018) (Million US$)
Table Europe Drug of Abuse (DOA) Testing Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Drug of Abuse (DOA) Testing Revenue Market Share by Countries
Figure Germany Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Germany Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure France Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure France Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure UK Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Italy Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Russia Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table Europe Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure 2017 Europe Drug of Abuse (DOA) Testing Market Share by Product
Table Europe Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table Europe Drug of Abuse (DOA) Testing Sales Market Share by End User (2013-2018)
Figure 2017 Europe Drug of Abuse (DOA) Testing Market Share by End User
Figure Asia Pacific Drug of Abuse (DOA) Testing Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Drug of Abuse (DOA) Testing Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Drug of Abuse (DOA) Testing Sales Market Share by Countries
Table Asia Pacific Drug of Abuse (DOA) Testing Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Drug of Abuse (DOA) Testing Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Drug of Abuse (DOA) Testing Revenue Market Share by Countries
Figure China Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure China Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Japan Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Korea Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure India Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure India Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Australia Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Drug of Abuse (DOA) Testing Market Share by Product
Table Asia Pacific Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Drug of Abuse (DOA) Testing Market Share by End User
Figure Central & South America Drug of Abuse (DOA) Testing Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Drug of Abuse (DOA) Testing Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Drug of Abuse (DOA) Testing Sales by Countries (2013-2018) (K Units)
Table Central & South America Drug of Abuse (DOA) Testing Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Drug of Abuse (DOA) Testing Sales Market Share by Countries
Table Central & South America Drug of Abuse (DOA) Testing Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Drug of Abuse (DOA) Testing Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Drug of Abuse (DOA) Testing Revenue Market Share by Countries
Figure Brazil Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table Central & South America Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Drug of Abuse (DOA) Testing Market Share by Product
Table Central & South America Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table Central & South America Drug of Abuse (DOA) Testing Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Drug of Abuse (DOA) Testing Market Share by End User
Figure Middle East and Africa Drug of Abuse (DOA) Testing Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Drug of Abuse (DOA) Testing Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by Countries
Table Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Drug of Abuse (DOA) Testing Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Drug of Abuse (DOA) Testing Revenue Market Share by Countries
Figure GCC Countries Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Drug of Abuse (DOA) Testing Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Drug of Abuse (DOA) Testing Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Drug of Abuse (DOA) Testing Market Share by Product
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Drug of Abuse (DOA) Testing Market Share by End User
Table Siemens Company Details
Table Siemens Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Siemens Recent Development

Table Merck Company Details
Table Merck Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Recent Development

Table Roche Company Details
Table Roche Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Roche Recent Development

Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Thermo Fisher Scientific Recent Development

Table Bio-Rad Company Details
Table Bio-Rad Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bio-Rad Recent Development

Table Abbott Company Details
Table Abbott Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Recent Development

Table Quest Diagnostics Company Details
Table Quest Diagnostics Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Quest Diagnostics Recent Development

Table Express Diagnostics Int'l Company Details
Table Express Diagnostics Int'l Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Express Diagnostics Int'l Recent Development

Table Psychemedics Company Details
Table Psychemedics Drug of Abuse (DOA) Testing Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Psychemedics Recent Development

Table Global Drug of Abuse (DOA) Testing Sales Forecast by Regions 2018-2025 (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Market Share Forecast by Regions 2018-2025
Table Global Drug of Abuse (DOA) Testing Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Drug of Abuse (DOA) Testing Revenue Market Share Forecast by Regions 2018-2025
Table Global Drug of Abuse (DOA) Testing Sales Forecast by Product 2018-2025 (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Market Share Forecast by Product 2018-2025
Table Global Drug of Abuse (DOA) Testing Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Drug of Abuse (DOA) Testing Revenue Market Share Forecast by Product 2018-2025
Table Global Drug of Abuse (DOA) Testing Sales Forecast by End User 2018-2025 (K Units)
Table Global Drug of Abuse (DOA) Testing Sales Market Share Forecast by End User 2018-2025
Figure North America Drug of Abuse (DOA) Testing Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Drug of Abuse (DOA) Testing Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Drug of Abuse (DOA) Testing Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Drug of Abuse (DOA) Testing Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Drug of Abuse (DOA) Testing Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Drug of Abuse (DOA) Testing Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Drug of Abuse (DOA) Testing Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Drug of Abuse (DOA) Testing Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Drug of Abuse (DOA) Testing Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Drug of Abuse (DOA) Testing Revenue Growth Rate Forecast (2018-2025) (Million US$)
Table Drug of Abuse (DOA) Testing Value Chain
Table Drug of Abuse (DOA) Testing Customers List
Table Drug of Abuse (DOA) Testing Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $4900
USD $8800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.